Publications
Events
Advertise
Subscribe
MyBN
Log In
Search
Menu
Close Navigation
Login
MyBN
Latest News
Resources
Property
Commercial Content
Back to previous menu
Close
Commercial Content
Announcements
Bulls N' Bears
Business Advice
Hearts & Minds
Industry Content
Skyline
Thought Leadership
All Categories
Back to previous menu
Close
All Categories
Resources
Property
Deals
Opinion
Government
Agribusiness
Education
Health
Infrastructure
Oil & Gas
Remuneration
Retail
Small Business
Technology, Innovation & Science
Tourism
Transport & Logistics
Explore All Categories
Data & Insights
Publications
Events
Advertise
Subscribe
Lists
Michael Stewart
Follow
Get notifications in MyBN when activity occurs.
Subscribe to BN
Log In
Michael Stewart
Michael Stewart has a broad corporate and management background, and has been extensively involved in bilateral donor funded and World Bank co-financed Aid Projects in under-developed countries.
Lists and Charts
Total Shareholder Return
as at 29/02/24
Rank
Company
1 yr
5 yr
10
th
Arovella Therapeutics
432%
110%
843
rd
AML3D
-8%
1364
th
Environmental Clean Technologies
-43%
-41%
1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Share Transactions
11/12/17
$0 Issued
Arovella Therapeutics
23/11/17
$11k Bought
Arovella Therapeutics
31/05/17
$100k Issued
Arovella Therapeutics
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
Rank
Company
Revenue
974
th
Arovella Therapeutics
$1.5m
1019
th
Asian American Medical Group
$851k
1020
th
Environmental Clean Technologies
$838k
1022
nd
AML3D
$818k
1023
rd
Rightcrowd
$805k
View Full List
1329 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Show All Lists and Charts
Collapse All Lists and Charts
News Articles
Related Information
Positions
- Previous
Position
Company
Year
Company's current rank
Non-Executive Director, Chair since 2014
Arovella Therapeutics
2009 - 2018
974
Directors Interests
Company
Date
Transaction type
Number of shares
Price per share
Transaction value
Nature of change
Arovella Therapeutics
11 Dec 2017
Issued
7,500,000
Other
Issue of securities
Arovella Therapeutics
23 Nov 2017
Bought
588,110
$0.02
$11,174
On-market trade
Arovella Therapeutics
31 May 2017
Issued
100,000
$1.00
$100,000
Other
Issue of securities
Arovella Therapeutics
11 May 2017
Other
5,000,000
Other
Options expired
Arovella Therapeutics
11 May 2017
Other
2,712,820
Other
As advised by the company: Expiry of Performance Rights.
View All
Powered by Morningstar ®
Equity Capital Markets Deals
Date
Company
Transaction Type
Total Value
30/03/15
Arovella Therapeutics
Placement
$5.3m
>>
View All
Subscribe today for award-winning, unbiased and trusted journalism
Subscription Options